JPMorgan Lifts CLINUVEL Voting Stake To Nearly 8%
CUV: $7.38 -2.77% · MC: $375M
JPMorgan Chase & Co. and its affiliates increased their relevant interest in CLINUVEL Pharmaceuticals to 7.96% from 6.53%. The notice includes securities lending and client-related interests, so the change should not be read simply as a share purchase.

Comments